Health Care / Medicine

The bill would require California’s Department of Health Care Access and Administration to provide grant funding to small and rural hospitals so they can achieve compliance amid times of severe financial distress

The collaboration, which was announced last week, is between Bicycle Health, Wellpath, and the Federal Bureau of Prisons. It will provide virtual opioid use disorder services to those living in the Bureau's residential reentry centers in 42 states.

The regulatory decision comes too late for the diagnostics developer, which has filed for bankruptcy protection.

With all this heat, what is the message from the head of the Pharmaceutical Care Management Association?

The current legal landscape makes access to medication abortion crucial in protecting as much access to reproductive healthcare as possible and in protecting healthcare providers’ abilities to do their jobs without fear of prosecution.

Today, 35 states have passed mandates for electronic prescriptions for controlled substances with the aim being to reduce the risk of stolen or forged prescriptions and to prevent patients from ‘doctor shopping’ between states.

The Senate Commerce Committee held a hearing which discussed how the Pharmacy Benefit Manager Transparency Act would affect practices by pharmacy benefit managers, including clawbacks. Some questioned why PBMs are even necessary.

The models, which include access to $2 generic drugs, build on the Inflation Reduction Act of 2022.

The increasing costs of labor and supplies are the top issues keeping healthcare CFOs up at night, according to a new report.

Here is a selection of recent executive hires, departures and layoffs occurring across the healthcare industry.

R&D spending rose in response to COVID-19, bringing with it higher expectations for returns on all biopharma investments. The once sky-high projections are coming down to Earth, with returns now in line with pre-pandemic levels, according to a new Deloitte report.

High prices have drawn other critics as well, including President Joe Biden. He renewed his call for a broad price cap during his annual State of the Union address. Pharma companies insist they have been part of the solution.

The COVID-19 public health emergency waived a rule that required a practitioner to conduct an in-person medical exam before prescribing controlled substances via telemedicine. Once the public health emergency ends on May 11, those with substance use disorder could be greatly affected, experts are warning.

Two Congresspeople recently introduced a bill seeking to terminate the VA's Oracle Cerner EHR rollout. The legislation said that the project is too flawed and costly to carry on — the lawmakers called for VA facilities to revert back to the department’s internally developed EHR.

Under the proposed new rule, employers are no longer able to be exempt from covering contraception due to moral convictions, but religious exemptions still remain. It's an important move from the government during the reproductive health crisis, one advocate said.

GoodRx failed to notify users that it sold their personal health information to Google, Facebook, and other tech companies, the FTC claimed. The agency filed an order that prohibits GoodRx from sharing its users' data with third parties for advertising purposes and requires the company to pay a $1.5 million penalty. GoodRx agreed to pay the settlement but did not admit to wrongdoing.

Now that numerous calls for repeal and legal challenges brought against the ACA over the years have failed, health plans can finally invest confidently in this line of business.

The agency’s goal is to spur a macro shift in clinical trials. The FDA is trying to tell these companies what it wants to be different in trials across the board with regards to digital health endpoints, the use of real-world data (RWD) as regulatory-grade data, and diversity in clinical trial inclusion.

After another insightful conference this year, these are some of the key legal deal trends to expect from the health care and life sciences industries in 2023.

A contentious debate regarding whether or not nurse practitioners should have more freedom and be less tethered to doctors continues as lawmakers in Pennsylvania spark discussion.